Dupilumab helps treat moderate to severe asthma in kids

Published On 2021-12-18 11:24 GMT | Update On 2021-12-18 11:24 GMT

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.

The findings of the international multicenter Liberty Asthma VOYAGE trial, reported Dec. 9 in the New England Journal of Medicine, supported approval of dupilumab for the treatment of moderate-to-severe asthma in this age group by the Food and Drug Administration in October.

For more details, check out the full story on the link below:

Dupilumab New Treatment Option For Moderate-To-Severe Asthma In Kids: NEJM

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Dupilumab helps treat moderate to severe asthma in kids

Similar News

Switch from Smoking to Vaping to Improve Respiratory Health: Study Finds

Rare Disease Show Episode 19: Decoding Pulmonary Arterial Hypertension with Dr Brajesh Kumar Mishra

Study Finds Pathophysiological Similarities Between Preeclampsia and COVID-19

Can a Child’s Current BMI Affect Their Future Lung Function? Study Sheds Light

Long Covid Common After Other Respiratory Tract Infections: Study Finds

New Handheld X-Ray Device May Enhance Early Detection and Treatment Efforts in TB: Study Reveals

Approximately 80 Percent Protection May be Provided by RSV Vaccine Against Severe Disease and Death: Study Suggests

Study Identifies Signs Tied to More Severe Cases of RSV